Coronary blood flow in renovascular hypertension

F. Magrini, P. Reggiani, G. Fratianni, A. Morganti, A. Zanchetti

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We assessed the acute effects of 2.5 mg oral cilazapril on systemic and coronary hemodynamics in seven renovascular hypertensive patients with a chronically overactive renin-angiotensin system (RAS), but with no electrocardiographic or echocardiographic signs of left ventricular hypertrophy. Cilazapril resulted in a significant decrease in mean arterial pressure and coronary vascular resistance, together with a prolonged increase in coronary sinus blood flow (CSBF). Post-cilazapril handgrip resulted in larger increases in CSBF in response to a given increase in myocardial oxygen requirements. It is concluded that the chronic activation of the RAS exerts an adverse influence on the control mechanisms of CSBF and that converting enzyme inhibition reverses the effects of angiotensin II on coronary hemodynamics. Converting enzyme inhibitors may have a cardioprotective role in renovascular hypertension.

Original languageEnglish
JournalAmerican Journal of Medicine
Volume94
Issue number4 A
Publication statusPublished - 1993

Fingerprint

Cilazapril
Renovascular Hypertension
Coronary Sinus
Renin-Angiotensin System
Hemodynamics
Left Ventricular Hypertrophy
Enzyme Inhibitors
Angiotensin II
Vascular Resistance
Arterial Pressure
Oxygen
Enzymes

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Magrini, F., Reggiani, P., Fratianni, G., Morganti, A., & Zanchetti, A. (1993). Coronary blood flow in renovascular hypertension. American Journal of Medicine, 94(4 A).

Coronary blood flow in renovascular hypertension. / Magrini, F.; Reggiani, P.; Fratianni, G.; Morganti, A.; Zanchetti, A.

In: American Journal of Medicine, Vol. 94, No. 4 A, 1993.

Research output: Contribution to journalArticle

Magrini, F, Reggiani, P, Fratianni, G, Morganti, A & Zanchetti, A 1993, 'Coronary blood flow in renovascular hypertension', American Journal of Medicine, vol. 94, no. 4 A.
Magrini F, Reggiani P, Fratianni G, Morganti A, Zanchetti A. Coronary blood flow in renovascular hypertension. American Journal of Medicine. 1993;94(4 A).
Magrini, F. ; Reggiani, P. ; Fratianni, G. ; Morganti, A. ; Zanchetti, A. / Coronary blood flow in renovascular hypertension. In: American Journal of Medicine. 1993 ; Vol. 94, No. 4 A.
@article{19a6eb6169764f2d9324f1b054c5748e,
title = "Coronary blood flow in renovascular hypertension",
abstract = "We assessed the acute effects of 2.5 mg oral cilazapril on systemic and coronary hemodynamics in seven renovascular hypertensive patients with a chronically overactive renin-angiotensin system (RAS), but with no electrocardiographic or echocardiographic signs of left ventricular hypertrophy. Cilazapril resulted in a significant decrease in mean arterial pressure and coronary vascular resistance, together with a prolonged increase in coronary sinus blood flow (CSBF). Post-cilazapril handgrip resulted in larger increases in CSBF in response to a given increase in myocardial oxygen requirements. It is concluded that the chronic activation of the RAS exerts an adverse influence on the control mechanisms of CSBF and that converting enzyme inhibition reverses the effects of angiotensin II on coronary hemodynamics. Converting enzyme inhibitors may have a cardioprotective role in renovascular hypertension.",
author = "F. Magrini and P. Reggiani and G. Fratianni and A. Morganti and A. Zanchetti",
year = "1993",
language = "English",
volume = "94",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "4 A",

}

TY - JOUR

T1 - Coronary blood flow in renovascular hypertension

AU - Magrini, F.

AU - Reggiani, P.

AU - Fratianni, G.

AU - Morganti, A.

AU - Zanchetti, A.

PY - 1993

Y1 - 1993

N2 - We assessed the acute effects of 2.5 mg oral cilazapril on systemic and coronary hemodynamics in seven renovascular hypertensive patients with a chronically overactive renin-angiotensin system (RAS), but with no electrocardiographic or echocardiographic signs of left ventricular hypertrophy. Cilazapril resulted in a significant decrease in mean arterial pressure and coronary vascular resistance, together with a prolonged increase in coronary sinus blood flow (CSBF). Post-cilazapril handgrip resulted in larger increases in CSBF in response to a given increase in myocardial oxygen requirements. It is concluded that the chronic activation of the RAS exerts an adverse influence on the control mechanisms of CSBF and that converting enzyme inhibition reverses the effects of angiotensin II on coronary hemodynamics. Converting enzyme inhibitors may have a cardioprotective role in renovascular hypertension.

AB - We assessed the acute effects of 2.5 mg oral cilazapril on systemic and coronary hemodynamics in seven renovascular hypertensive patients with a chronically overactive renin-angiotensin system (RAS), but with no electrocardiographic or echocardiographic signs of left ventricular hypertrophy. Cilazapril resulted in a significant decrease in mean arterial pressure and coronary vascular resistance, together with a prolonged increase in coronary sinus blood flow (CSBF). Post-cilazapril handgrip resulted in larger increases in CSBF in response to a given increase in myocardial oxygen requirements. It is concluded that the chronic activation of the RAS exerts an adverse influence on the control mechanisms of CSBF and that converting enzyme inhibition reverses the effects of angiotensin II on coronary hemodynamics. Converting enzyme inhibitors may have a cardioprotective role in renovascular hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0027922722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027922722&partnerID=8YFLogxK

M3 - Article

VL - 94

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 4 A

ER -